Control of Hypertension In Pregnancy Study randomised controlled trial—are the results dependent on the choice of labetalol or methyldopa?

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 123, Issue 7, 2016, Pages 1135-1141

  Magee, L A ^a   von Dadelszen, P ^a   Singer, J ^a,b   Lee, T ^b   Rey, E ^c   Ross, S ^d   Asztalos, E ^e   Murphy, K E ^e   Menzies, J ^a   Sanchez, J ^e   Gafni, A ^f   Gruslin, A ^g   Helewa, M ^h   Hutton, E ^f   Koren, G ^e   Lee, S K ^e   Logan, A G ^e   Ganzevoort, J W ⁱ   Welch, R ^j   Thornton, J G ^k   Moutquin, J M ^l   more..

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b PROVIDENCE HEALTH CARE RESEARCH INSTITUTE   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

^h UNIVERSITY OF MANITOBA   (Canada)

ⁱ UNIVERSITY OF AMSTERDAM   (Netherlands)

^j DERRIFORD HOSPITAL   (United Kingdom)

^k UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^l UNIVERSITÉ DE SHERBROOKE   (Canada)

more..

Author keywords

Antihypertensive therapy; hypertension; labetalol; methyldopa; pregnancy

Indexed keywords

LABETALOL; METHYLDOPA; PLACEBO;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; LOW BIRTH WEIGHT; MATERNAL HYPERTENSION; NEWBORN CARE; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; SENSITIVITY ANALYSIS; TREATMENT OUTCOME;

EID: 84978394429     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.13568     Document Type: Article

References (16)

1. Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2014;2:CD002252.
2. Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med 2015;29:407–17.
3. Dasgupta K, Quinn RR, Zarnke KB, Rabi DM, Ravani P, Daskalopoulou SS, et al. The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 2014;30:485–501.
4. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013;122:1122–31.
5. Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P, Magee LA, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can 2014;36:416–38.
6. Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P, on behalf of the Canadian Hypertensive Disorders of Preganncy (HDP) Working Group. Diagnosis, evaluation and management of the hypertensive disorders of pregnancy. Pregnancy Hypertension 2014;4:105–45.
7. National Institute for Health and Clinical Excellence. Hypertension in pregnancy: The management of hypertensive disorders during pregnancy. guidance nice org uk/cg107. London: NICE, 2013.
8. Nederlandse Vereniging voor Obstetrie Gynaecologie (The Dutch Society of Obstetrics and Gynaecology). Hypertensieve aandoeningen in de zwangerschap. 2011 [www nvog nl]. Accessed 1 November 2013.
9. Gillon TE, Pels A, von Dadelszen P, MacDonell K, Magee LA. Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines. PLoS ONE 2014;9:e113715.
10. Bateman BT, Hernandez-Diaz S, Huybrechts KF, Palmsten K, Mogun H, Ecker JL, et al. Patterns of outpatient antihypertensive medication use during pregnancy in a medicaid population. Hypertension 2012;60:913–20.
11. Xie RH, Guo Y, Krewski D, Mattison D, Nerenberg K, Walker MC, et al. Trends in using β-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population. Eur J Obstet Gynecol Reprod Biol 2013;171:281–5.
12. Magee LA, Duley L. Oral β-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2003;CD002863.
13. Magee LA, Helewa M, Rey E, Cote AM, Douglas J, Gibson P, et al. SOGC Clinical Practice Guideline: diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. JOGC 2008;30:S1–48.
14. Blake S, MacDonald D. The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment. Br J Obstet Gynaecol 1991;98:244–8.
15. El Guindy AA, Nabhan AF. A randomized trial of tight vs. less tight control of mild essential and gestational hypertension in pregnancy. J Perinat Med 2008;36:413–18.
16. Magee LA, von Dadelszen P, Chan S, Gafni A, Gruslin A, Helewa M, et al. The control of hypertension in pregnancy study pilot trial. BJOG 2007;114:770, e13–770, e20.